CD19 and neoplasm: Analysis of the growth of subcutaneous OCI-Ly3 tumors demonstrated that both IL-12-secreting CD19 CARs (CAR19/hIL12 and CAR19/hIL12ODD) prevented tumor outgrowth by 30 days compared to CAR19 and UTD T cell groups (Figures 4B and S4B).